Liu Linda 4
4 · NextCure, Inc. · Filed Feb 21, 2020
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Liu Linda
SVP, Research
Transactions
- Exercise/Conversion
Common Stock
2019-11-27$0.48/sh+34,489$16,555→ 34,489 total - Exercise/Conversion
Common Stock
2019-11-27$1.21/sh+20,745$25,101→ 55,234 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-11-27−34,489→ 9,076 totalExercise: $0.48Exp: 2026-09-01→ Common Stock (34,489 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-11-27−20,745→ 10,373 totalExercise: $1.21Exp: 2027-03-15→ Common Stock (20,745 underlying)
Footnotes (2)
- [F1]One fourth of the option vested on September 1, 2017. The remainder vests in 36 monthly installments beginning on October 1, 2017.
- [F2]One fourth of the option vested on March 15, 2018. The remainder vests in 36 monthly installments beginning on April 15, 2018.